1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom (Cl), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause other adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
Example: Rule 1: If a molecule contains a sulfonamide functional group, it is likely to cause adverse effects.
Example: Rule 2: If a molecule contains a nitro functional group, it is likely to cause adverse effects.
Example: Rule 3: If a molecule contains both a sulfonamide and a nitro functional group, it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, bromine, or iodine), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If the molecule contains any functional groups that are known to cause skin and subcutaneous tissue disorders, such as amides, esters, or aldehydes, it is more likely to cause adverse effects.
2. Rule 2: If the molecule has a high lipophilicity (i.e., it is highly soluble in nonpolar solvents), it is more likely to cause adverse effects.
3. Rule 3: If the molecule has a high polarity (i.e., it is highly soluble in polar solvents), it is less likely to cause adverse effects.
These rules are based on the assumption that molecules with these properties are more likely to interact with skin and subcutaneous tissue, leading to adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group such as an amide, imide, or urea group, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The given molecule contains a nitro group (-NO2), which is associated with skin and subcutaneous tissue disorders. Therefore, this molecule is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The given molecule contains a halogen atom (such as fluorine, chlorine, or bromine), which is associated with skin and subcutaneous tissue disorders. Therefore, this molecule is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The given molecule contains a carbonyl group (-C=O), which is associated with skin and subcutaneous tissue disorders. Therefore, this molecule is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO 1" contains a nitro group (-NO2). Therefore, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The molecule with the smiles string "COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC 1" contains a halogen atom (fluorine). Therefore, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The molecule with the smiles string "CC(C(C1=CC=CC=C1)O)N 1" contains a carbonyl group (-C=O). Therefore, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause eye disorders, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause respiratory disorders, it is likely to cause adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for the presence of specific functional groups that are known to be associated with adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is likely to cause adverse effects.
These rules are based on the assumption that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogen atom (such as chlorine or bromine), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is less likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amide, imide, or urea group, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogen atom such as chlorine, bromine, or iodine, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups or atoms are more likely to cause adverse effects related to skin and subcutaneous tissue disorders. However, it is important to note that these rules are not always accurate and should be used with caution.

================================

1. Rule 1: If the molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, such as a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If the molecule has a high lipophilicity (i.e., is highly hydrophobic), it is more likely to cause adverse effects.
3. Rule 3: If the molecule has a high molecular weight, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects. For example, if a molecule contains a sulfonamide group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule has a high molecular weight, it is likely to cause adverse effects. For example, if a molecule has a molecular weight greater than 500, it is likely to cause adverse effects. Therefore, if a molecule has a molecular weight greater than 500, it is likely to cause adverse effects.
3. Rule 3: If a molecule has a polar functional group, it is likely to cause adverse effects. For example, if a molecule has a hydroxyl group, it is likely to cause adverse effects. Therefore, if a molecule has a polar functional group, it is likely to cause adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F 1) contains a nitro group (-NO2), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The second molecule (CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl 1) contains a halogen atom (chlorine), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The third molecule (C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The fourth molecule (C1=CC=C(C=C1)CO 1) contains a carbonyl group (-C=O), which is also known to cause adverse effects related to skin and subcutaneous tissue disorders.
The fifth molecule (C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The sixth molecule (COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC 1) contains a carbonyl group (-C=O), which is also known to cause adverse effects related to skin and subcutaneous tissue disorders.
The seventh molecule (CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The eighth molecule (C1=CC(=C(C=C1C(=N)N)Br)OCCCOC2=C(C=C(C=C2)C(=N)N)Br.C(CS(=O)(=O)O)O 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The ninth molecule ([La] 0) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The tenth molecule (C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The eleventh molecule (CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to skin and subcutaneous tissue disorders.
The twelfth molecule (CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5 1) contains

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for the presence of specific functional groups that are known to be associated with adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects. For example, if a molecule contains a sulfonamide group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule has a high molecular weight, it is likely to cause adverse effects. For example, if a molecule has a molecular weight greater than 500, it is likely to cause adverse effects. Therefore, if a molecule has a molecular weight greater than 500, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a halogen atom, it is likely to cause adverse effects. For example, if a molecule contains a chlorine atom, it is likely to cause adverse effects. Therefore, if a molecule contains a chlorine atom, it is likely to cause adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a benzene ring, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a carboxylic acid group, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the data as follows:
1. Rule 1: The first molecule, [H-].[H-].[Ba+2] 0, does not contain a benzene ring, but it does contain a carboxylic acid group. Therefore, it is not likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The second molecule, C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N 1, does not contain a benzene ring, but it does contain a carboxylic acid group. Therefore, it is not likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The third molecule, COC1=CC=CC=C1OCC(COC(=O)N)O 1, does not contain a benzene ring, but it does contain a carboxylic acid group. Therefore, it is not likely to cause adverse effects related to skin and subcutaneous tissue disorders.
The fourth molecule, C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1 1, does not contain a benzene ring, but it does contain a carboxylic acid group. Therefore, it is not likely to cause adverse effects related to skin and subcutaneous tissue disorders.
The fifth molecule, CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C 1, does not contain a benzene ring, but it does contain a carboxylic acid group. Therefore, it is not likely to cause adverse effects related to skin and subcutaneous tissue disorders.
The sixth molecule, C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F 1, does not contain a benzene ring, but it does contain a carboxylic acid group. Therefore, it is not likely to cause adverse effects related to skin and subcutaneous tissue disorders.
The seventh molecule, CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause gastrointestinal disorders, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause respiratory disorders, it is likely to cause adverse effects.
For the first molecule, the functional group is -C=O, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
For the second molecule, the functional group is -COOH, which is known to cause gastrointestinal disorders. Therefore, it is likely to cause adverse effects.
For the third molecule, the functional group is -CN, which is known to cause respiratory disorders. Therefore, it is likely to cause adverse effects.
For the fourth molecule, the functional group is -C=O, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
For the fifth molecule, the functional group is -CN, which is known to cause respiratory disorders. Therefore, it is likely to cause adverse effects.
For the sixth molecule, the functional group is -C=O, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
For the seventh molecule, the functional group is -CN, which is known to cause respiratory disorders. Therefore, it is likely to cause adverse effects.
For the eighth molecule, the functional group is -C=O, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
For the ninth molecule, the functional group is -CN, which is known to cause respiratory disorders. Therefore, it is likely to cause adverse effects.
For the tenth molecule, the functional group is -C=O, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
For the eleventh molecule, the functional group is -CN, which is known to cause respiratory disorders. Therefore, it is likely to cause adverse effects.
For the twelfth molecule, the functional group is -C=O, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
For the thirteenth molecule, the functional group is -CN, which is known to cause respiratory

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to be toxic, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause adverse effects, it is likely to cause adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a tertiary amine group (-N(CH3)3), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for the presence of specific functional groups that are known to be associated with adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects. For example, if a molecule contains a sulfonamide group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is likely to cause adverse effects. For example, if a molecule contains a hydroxyl group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a hydroxyl group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is likely to cause adverse effects. For example, if a molecule contains a benzene ring, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a benzene ring, it is likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a fluorine atom (-F), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 1, "CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6", contains a nitro group (-NO2). This suggests that the presence of a nitro group in a molecule may be associated with adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The molecule with label 1, "C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@H]2[C@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F", contains a fluorine atom (-F). This suggests that the presence of a fluorine atom in a molecule may be associated with adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The molecule with label 1, "C(CS(=O)(=O)O)S 1", contains a carbonyl group (-C=O). This suggests that the presence of a carbonyl group in a molecule may be associated with adverse effects related to skin and subcutaneous tissue disorders

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause gastrointestinal disorders, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause respiratory disorders, it is likely to cause adverse effects.
These rules are based on the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (-C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules are based on the observation that molecules containing these functional groups are more likely to cause adverse effects related to skin and subcutaneous tissue disorders. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects. For example, if a molecule contains a sulfonamide group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is likely to cause adverse effects. For example, if a molecule contains a hydroxyl group, it is polar and polar functional groups are known to cause adverse effects. Therefore, if a molecule contains a hydroxyl group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is likely to cause adverse effects. For example, if a molecule contains a benzene ring, it is known to cause adverse effects. Therefore, if a molecule contains a benzene ring, it is likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains any functional groups such as aldehydes, ketones, amides, or carboxylic acids, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains any halogen atoms such as fluorine, chlorine, bromine, or iodine, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains any aromatic rings, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a magnesium ion (Mg+2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a chlorine atom (Cl), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred by analyzing the structures and properties of the molecules and comparing them to the labels provided in the data. For example, the first molecule (C1=CC(=CC=C1CN)S(=O)(=O)N 1) contains a carbonyl group and is labeled as causing adverse effects related to skin and subcutaneous tissue disorders (label 1). Similarly, the second molecule ([Mg+2] 1) contains a magnesium ion and is also labeled as causing adverse effects related to skin and subcutaneous tissue disorders (label 1). The third molecule (CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)

================================

1. Rule 1: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause other adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
These rules can be inferred from the given data by analyzing the structures of the molecules and identifying the functional groups that are present. The data also provides information about the side-effect activity of the molecules, which can be used to validate these rules.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a functional group such as a sulfonamide, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules are based on the observation that molecules containing these functional groups are commonly associated with skin and subcutaneous tissue disorders. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group such as an amide group (-C=O-NH-) or a carboxylic acid group (-COOH), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom (-Cl), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects. For example, if a molecule contains a sulfonamide group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is likely to cause adverse effects. For example, if a molecule contains a hydroxyl group, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a hydroxyl group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a ring structure, it is likely to cause adverse effects. For example, if a molecule contains a benzene ring, it is known to cause skin and subcutaneous tissue disorders. Therefore, if a molecule contains a benzene ring, it is likely to cause adverse effects.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, such as a sulfonamide group, then it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a functional group that is known to cause gastrointestinal disorders, such as a sulfonamide group, then it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a functional group that is known to cause respiratory disorders, such as a sulfonamide group, then it is likely to cause adverse effects.
These rules can be inferred from the given data as follows:
1. Rule 1: The given molecule contains a sulfonamide group, which is known to cause skin and subcutaneous tissue disorders. Therefore, it is likely to cause adverse effects.
2. Rule 2: The given molecule contains a sulfonamide group, which is known to cause gastrointestinal disorders. Therefore, it is likely to cause adverse effects.
3. Rule 3: The given molecule contains a sulfonamide group, which is known to cause respiratory disorders. Therefore, it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause other adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects more frequently.
In the given data, the first molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects. The second molecule contains a functional group that is known to cause other adverse effects, so it is likely to cause skin and subcutaneous tissue disorders as well. The third molecule contains multiple functional groups that are known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects more frequently.
The fourth molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects. The fifth molecule contains a functional group that is known to cause other adverse effects, so it is likely to cause skin and subcutaneous tissue disorders as well. The sixth molecule contains multiple functional groups that are known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects more frequently.
The seventh molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects. The eighth molecule contains a functional group that is known to cause other adverse effects, so it is likely to cause skin and subcutaneous tissue disorders as well. The ninth molecule contains multiple functional groups that are known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects more frequently.
The tenth molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects. The eleventh molecule contains a functional group that is known to cause other adverse effects, so it is likely to cause skin and subcutaneous tissue disorders as well. The twelfth molecule contains multiple functional groups that are known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects more frequently.
The thirteenth molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, so it is likely to cause adverse effects. The fourteenth molecule contains a functional group that is known to cause other adverse effects, so it is likely to cause skin

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is likely to cause adverse effects.
3. Rule 3: If a molecule has a high molecular weight, it is likely to cause adverse effects.
These rules are based on the observation that molecules with these properties are more likely to cause adverse effects in humans. However, it is important to note that these rules are not foolproof and there may be exceptions to each rule. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl, contains a carbonyl group (-C=O). Therefore, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The molecule with label 1, CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2, contains a chlorine atom. Therefore, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The molecule with label 1, CCC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N, contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a nitrogen atom, it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with the smiles string "CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43" contains a carbonyl group (C=O) and is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The molecule with the smiles string "CC1=C(C=CC2=C1C(=[NH+]C(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC" contains a nitrogen atom and is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The molecule with the smiles string "CC1=C2[C@@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC" contains a halogen atom (fluorine) and is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the given data by analyzing the structures and labels of the molecules. The data shows that molecules with nitro groups, halogen atoms, and carbonyl groups are more likely to have adverse effects related to skin and subcutaneous tissue disorders. Therefore, these groups can be used as indicators of potential adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a tertiary amine group (-N(CH3)3), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 1 (related to skin and subcutaneous tissue disorders) contains a sulfonamide group (-SO2NH2). This group is commonly found in drugs that are used to treat skin and subcutaneous tissue disorders such as eczema, psoriasis, and rashes. Therefore, the presence of a sulfonamide group in a molecule is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: The molecule with label 0 (not related to skin and subcutaneous tissue disorders) does not contain a sulfonamide group (-SO2NH2). Therefore, the presence of a carboxylic acid group (-COOH) in a molecule is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: The molecule with label 0 (not related to skin and subcutaneous tissue disorders) does not contain a tertiary amine group (-N(CH3)3). Therefore, the presence of a tertiary amine group (-N(CH3)3) in a molecule is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to skin and subcutaneous tissue disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause other adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause other adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
For example, the molecule COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC may contain a functional group that is known to cause skin and subcutaneous tissue disorders, as well as a functional group that is known to cause other adverse effects. Therefore, it is likely to cause adverse effects.
Similarly, the molecule CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC may contain a functional group that is known to cause skin and subcutaneous tissue disorders, as well as a functional group that is known to cause other adverse effects. Therefore, it is likely to cause adverse effects.
The molecule CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O may contain a functional group that is known to cause skin and subcutaneous tissue disorders, as well as a functional group that is known to cause other adverse effects. Therefore, it is likely to cause adverse effects.
The molecule CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O may contain a functional group that is known to cause skin and subcutaneous tissue disorders, as well as a functional group that is known to cause other adverse effects. Therefore, it is likely to cause adverse effects.
The molecule B1(C2=C(CO1)C=C(C=C2)F)O may contain a functional group that is known to cause skin and subcutaneous tissue disorders, as well as a functional group that is known to cause other adverse effects. Therefore, it is likely to cause adverse

================================

1. Rule 1: If a molecule contains a functional group that is known to cause skin and subcutaneous tissue disorders, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause other adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
3. Rule 3: If a molecule contains multiple functional groups that are known to cause adverse effects, it is likely to cause skin and subcutaneous tissue disorders as well.
These rules can be inferred from the given data by analyzing the structures of the molecules and identifying the functional groups that are present. The data also provides information about the side-effect activity of the molecules, which can be used to validate the rules.

================================

